| E2 | estrogen |
| E3 | estriol |
| PPARα | peroxisome proliferator-activated receptor α |
| PPARβ | peroxisome proliferator-activated receptor β |
| PGC1α | peroxisome proliferator-activated receptor gamma coactivator 1 α |
| PCG1β | peroxisome proliferator-activated receptor gamma coactivator 1 β |
| ERR1 | estrogen-related receptor 1 |
| BMI | body mass index |
| SWAN | Study of Women’s Health Across the Nation |
| SAT | subcutaneous adipose tissue |
| TG | triacylglycerol |
| TC | total cholesterol |
| FFA | free fatty acid |
| AT-LPL | adipose tissue lipoprotein lipase |
| FFM | fat-free mass |
| LBM | lean body mass |
| DEXA | dual-energy X-ray absorptiometry |
| BMR | basal metabolic rate |
| REE | resting energy expenditure |
| VLDLs | very-low-density lipoproteins |
| LDLs | low-density lipoproteins |
| HDLs | high-density lipoproteins |
| LCAT | lecithin-cholesterol acyltransferase |
| CETP | cholesterol ester transfer protein |
| CHD | coronary heart disease |
| FSH | follicle-stimulating hormone |
| WHILA | Women’s Health in the Lund Area |
| OVX | ovariectomized |
| CEBPb | CCAAT-enhancer-binding proteins |
| ER α | estrogen receptor α |
| ER β | estrogen receptor β |
| Adipo ER α | adipocyte-specific ER α |
| AHA | American Heart Association |
| ACC | American College of Cardiology |
| RDA | Recommended dietary allowance |
| CVD | cardiovascular disease |
| DHA | docosahexaenoic acid |
| EPA | eicosapentaenoic acid |
| PUFA | polyunsaturated fatty acid |
| CHD | coronary heart disease |
| HRT | hormone replaces therapy |
| TBX2 | thromboxane B2 |